A NEUPRO patch is a transdermal system designed to deliver medication through the skin. It is specifically known as the first and only "patch" for Parkinson's disease, worn on the skin.
Understanding the NEUPRO Patch
The NEUPRO patch is a unique medication delivery system that provides a steady, continuous supply of its active ingredient.
Key Characteristics
This innovative patch is designed for consistent and stable medication delivery.
- Active Ingredient: The NEUPRO patch delivers rotigotine, which is a dopamine agonist. Dopamine agonists mimic the effects of dopamine in the brain.
- Delivery Method: The medication is delivered through the skin (transdermally) directly into the bloodstream, bypassing the digestive system.
- Continuous Release: It releases the medicine 24 hours a day, ensuring a stable and continuous supply of rotigotine.
- Application: It is designed to be worn on the skin, making it a convenient alternative to oral medications for some individuals.
How it Works
The patch works by slowly releasing rotigotine from its adhesive matrix into the skin, where it is then absorbed into the bloodstream. This transdermal delivery ensures a consistent concentration of the medication in the body throughout the day and night.
| Feature | Description |
|---|---|
| Type | Transdermal System (Skin Patch) |
| Active Ingredient | Rotigotine (Dopamine Agonist) |
| Delivery Mechanism | Through skin, directly into bloodstream |
| Medication Release | Continuous, 24 hours a day |
| Primary Benefit | Stable, continuous medication delivery |
Benefits of Continuous Delivery
The continuous 24-hour delivery of rotigotine via the NEUPRO patch offers a significant advantage. Unlike oral medications that might lead to fluctuating drug levels throughout the day as doses are taken and metabolized, the patch provides a stable and consistent therapeutic level of medication. This can help to manage symptoms more smoothly and avoid the "on-off" fluctuations that can sometimes occur with intermittent dosing.
